Tech Company Financing Transactions
KBI Biopharma Funding Round
KBI Biopharma closed a $7.4 million Series A funding round on 3/2/2009. Backers included private investors.
Transaction Overview
Company Name
Announced On
3/2/2009
Transaction Type
Venture Equity
Amount
$7,400,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1101 Hamlin Rd.
Durham, NY 27704
USA
Durham, NY 27704
USA
Phone
Website
Email Address
Overview
KBI Biopharma, founded in 1996, is a leading contract development organization for the biopharmaceutical industry. We accelerate and optimize drug development and manufacturing programs for our client partners, including global pharmaceutical and biotechnology companies and organizations in bio-defense.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dirk Lange
Vice President
Wayne Yount
VP - Bus. Development
Stewart McNaull
VP - Engineering
Thomas Milici
VP - General Counsel
Rachel Mandell
VP - Regulatory Affairs
Kathy Lee
Browse more venture capital transactions:
Prev: 3/2/2009: NeoSystems venture capital transaction
Next: 3/2/2009: Zenprise venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs